Is CLSD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLSD. It does not provide personalized investment advice.

CLSD (Clearside Biomedical, Inc. Common Stock) Stock Analysis - Financials

Clearside Biomedical, Inc. Common Stock (CLSD) is a publicly traded Healthcare sector company. As of July 15, 2026, CLSD trades at $0.41 with a market cap of $2.15M and a P/E ratio of 0.28. CLSD moved -28.07% today. Year to date, CLSD is -96.76%; over the trailing twelve months it is -97.47%. Its 52-week range spans $0.37 to $17.10. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces CLSD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CLSD's key financials?

CLSD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLSD recently traded at $0.41. Market cap is $2.15M. P/E ratio is 0.28. Revenue is $3.33M.

CLSD Key Metrics

Key financial metrics for CLSD
Metric	Value
Price	$0.41
Market Cap	$2.15M
P/E Ratio	0.28
EPS	$1.47
Dividend Yield	0.00%
52-Week High	$17.10
52-Week Low	$0.37
Volume	2.77M
Avg Volume	0
Revenue (TTM)	$3.33M
Net Income	$-26.00M
Gross Margin	0.00%

CLSD Analyst Consensus

8 analysts cover CLSD: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.

Common questions about CLSD

What are CLSD's key financials?: CLSD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLSD recently traded at $0.41. Market cap is $2.15M. P/E ratio is 0.28. Revenue is $3.33M.
Is CLSD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLSD. It does not provide personalized investment advice.